DeepMed Research

Peking University First Hospital (Peking Univesity First Medical School)

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

The Effect of Sleep Apnea and Hypertension on Gut Microbiome

Completed

Conditions: Obstructive Sleep Apnea
Hypertension
Gut Microbiome

First Posted Date: 2022-03-04

Last Posted Date: 2024-10-22

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 52

Registration Number: NCT05266131

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Nocturnal Low-dose Dexmedetomidine Infusion and Perioperative Sleep Quality

Not Applicable

Not yet recruiting

Conditions: Hip Replacement Surgery
Knee Replacement Surgery
Sleep Quality
Dexmedetomidine
Old Age

Interventions: Drug: Normal Saline
Drug: Dexmedetomidine

First Posted Date: 2022-02-18

Last Posted Date: 2022-04-20

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 432

Registration Number: NCT05246007

Locations: 🇨🇳
Beijing Hospital, Beijing, Beijing, China
🇨🇳
Peking University First Hospital, Beijing, Beijing, China

General Anesthetics-related Changes in Prefrontal EEG During Pediatric Surgical Anesthesia

Recruiting

Conditions: General Anesthetic
Electroencephalogram

Interventions: Drug: propofol
Drug: S-ketamine
Drug: sevoflurane

First Posted Date: 2022-01-27

Last Posted Date: 2024-03-20

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 366

Registration Number: NCT05210764

Locations: 🇨🇳
Peking University First Hospital, Beijing, China

Goal-directed Hemodynamic Management and Kidney Injury After Radical Nephrectomy or Nephroureterectomy

Not Applicable

Not yet recruiting

Conditions: Nephrectomy
Nephroureterectomy
Hemodynamic Management
Acute Kidney Injury
Chronic Kidney Diseases

Interventions: Other: Targeted hemodynamic management
Other: Routine care

First Posted Date: 2021-12-08

Last Posted Date: 2024-10-24

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 1724

Registration Number: NCT05149196

Locations: 🇨🇳
Beijing University First Hospital, Beijing, Beijing, China

Pembrolizumab Monotherapy Following Tri-modality Treatment for Selected Patients With Muscle-invasive Bladder Cancer

Phase 2

Recruiting

Conditions: Bladder Cancer
Bladder Neoplasms
Bladder Tumors
Urinary Bladder Cancer
Neoplasms, Bladder

Interventions: Drug: Pembrolizumab

First Posted Date: 2021-10-11

Last Posted Date: 2022-01-10

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 54

Registration Number: NCT05072600

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

A Study on the Efficacy of a Novel Approach to Achieving Laparoscopic Distal Rectal Transection for Rectal Cancers

Not Applicable

Conditions: Rectal Neoplasms Malignant

Interventions: Procedure: Transanterior obturator nerve gateway approach
Procedure: Total mesorectal excision approach

First Posted Date: 2021-10-05

Last Posted Date: 2021-10-05

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 200

Registration Number: NCT05067413

Locations: 🇨🇳
The Second Affiliated Hospital of Baotou Medical University, Baotou, Inner Mongolia, China
🇨🇳
Dalian University Affiliated Xinhua Hospital, Dalian, Liaoning, China
🇨🇳
Shengli Oilfield Hospital, Dongying, Shandong, China

and more 1 locations

Early Health Warning Intervention in Tobacco Control

Not Applicable

Conditions: Smoking Cessation

Interventions: Other: early health warning intervention

First Posted Date: 2021-08-09

Last Posted Date: 2021-08-09

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 1000

Registration Number: NCT04996329

Locations: 🇨🇳
The Second Hospital of Jilin University, Ch'ang-ch'un, China
🇨🇳
Shanxi Bethune Hospital, Taiyuan, China
🇨🇳
The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China

and more 7 locations

The Efficacy and Safety of 12-week SOF/VEL Regimen Combined With Prophylactic Use of TAF for Treatment-naïve Genotype 1-6 HCV/HBV Co-infection Adult Patients With or Without Compensated Cirrhosis in China

Phase 4

Conditions: Chronic Hepatitis C
Chronic Hepatitis B

Interventions: Drug: Tenofovir Alafenamide 25 MG
Drug: Sofosbuvir / Velpatasvir

First Posted Date: 2021-08-09

Last Posted Date: 2021-08-09

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 120

Registration Number: NCT04997564

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

A Cohort Study of Chronic Cardiovascular Diseases

Recruiting

Conditions: Cohort Studies
Cardiovascular Diseases

First Posted Date: 2021-08-09

Last Posted Date: 2021-08-09

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 10000

Registration Number: NCT04996342

Locations: 🇨🇳
Division of Cardiology, Peking University First Hospital, Beijing, 北京, China

Analgesic Effects of Low-dose S-ketamine in Major Spine Fusion Surgery

Phase 4

Recruiting

Conditions: Spine Fusion
S-ketamine
Postoperative Analgesia

Interventions: Drug: Placebo
Drug: S-ketamine

First Posted Date: 2021-07-16

Last Posted Date: 2024-05-09

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 164

Registration Number: NCT04964219

Locations: 🇨🇳
Beijing University First Hospital, Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy